Masimo and Mdoloris Medical Systems have announced the availability of CE marked Mdoloris Analgesia Nociception Index (ANI) module for the Masimo Root Patient Monitoring and Connectivity Hub.
The ANI module is the result of a Masimo Open Connect (MOC) third-party partnership between Mdoloris and Masimo.
Masimo noted that the integration of medical technology through Masimo Open Connect partnerships will address some barriers to new technology adoption to monitor patients.
Masimo founder and CEO Joe Kiani said: “With the ongoing expansion of its capabilities, Root becomes a more powerful bedside platform than ever.
“We believe that Root with Masimo Open Connect can do for patient monitoring what the PC did for computing: speed up the patient monitoring innovation cycle, reduce the cost of patient monitoring, and prolong the useful life of the equipment hospitals invest in.”
With the open architecture and advanced connectivity of the Root platform, third-party companies will be able to bypass barriers and the time taken for traditional multi-parameter monitor integration by controlling their own Root integration projects.
The companies can then develop, obtain regulatory approvals independently and later on commercialise their own external MOC-9 module or MOC-C app for Root using Masimo’s MOC software development kit.
Mdoloris Medical Systems founder and CEO Fabien Pagniez said: “We consider Masimo to be the most innovative company in the patient monitoring space and we believe Root offers a unique and compelling solution for implementing our ANI technology.”
Last month, Masimo secured CE mark for brain function monitoring device SedLine, which will be available for children aged one year and above.